Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-031663
Filing Date
2013-05-30
Accepted
2013-05-30 17:49:28
Documents
1
Period of Report
2013-05-30

Document Format Files

Seq Description Document Type Size
1 rrd380157.html 3  
1 rrd380157.xml 3 3611
  Complete submission text file 0001181431-13-031663.txt   4830
Mailing Address
Business Address
KERINS PATRICK J (Reporting) CIK: 0001235112 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35945 | Film No.: 13882955

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations